Next Article in Journal
Effects of Fullerenols on Mouse Brain Microvascular Endothelial Cells
Next Article in Special Issue
Neuroprotective and Nerve Regenerative Approaches for Treatment of Erectile Dysfunction after Cavernous Nerve Injury
Previous Article in Journal
Enhanced Cell Growth of Adipocyte-Derived Mesenchymal Stem Cells Using Chemically-Defined Serum-Free Media
Previous Article in Special Issue
Differential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma Cells
Article Menu
Issue 8 (August) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2017, 18(8), 1777;

Advances in Understanding of Penile Carcinogenesis: The Search for Actionable Targets

Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA
Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA
Department of Urology, Temple University, Philadelphia, PA 19140, USA
Department of Biological Sciences, University of Notre Dame, South Bend, IN 46556, USA
Author to whom correspondence should be addressed.
Received: 1 August 2017 / Revised: 13 August 2017 / Accepted: 14 August 2017 / Published: 16 August 2017
(This article belongs to the Special Issue Molecular Research on Urology)
Full-Text   |   PDF [781 KB, uploaded 16 August 2017]   |  


Penile cancer (PeCa) is a rare malignancy with potentially devastating effects. Squamous cell carcinoma is the most common variant with distinct precancerous lesions before development into invasive disease. Involvement of the inguinal lymph nodes is the most important prognostic factor in PeCa, and once disease is present outside the groin, prognosis is poor. Metastatic PeCa is challenging to treat and often requires multidisciplinary approaches in management. Due to its rarity, molecular understanding of the disease continues to be limited with most studies based on small, single center series. Thus far, it appears PeCa has diverse mechanisms of carcinogenesis affecting similar molecular pathways. In this review, we evaluate the current landscape of the molecular carcinogenesis of PeCa and explore ongoing research on potential actionable targets of therapy. The emergence of anti-epidermal growth factor receptor (EGFR) and other immunotherapeutic strategies may improve outcomes for PeCa patients. View Full-Text
Keywords: penile cancer; molecular carcinogenesis; actionable targets penile cancer; molecular carcinogenesis; actionable targets

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Chipollini, J.; Chaing, S.; Azizi, M.; Kidd, L.C.; Kim, P.; Spiess, P.E. Advances in Understanding of Penile Carcinogenesis: The Search for Actionable Targets. Int. J. Mol. Sci. 2017, 18, 1777.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top